Sanofi (EPA:SAN)
France · Delayed Price · Currency is EUR 80.98
+0.35 (0.43%)
Nov 3, 2026, 5:39 PM CET
Sanofi Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 50,982 | 46,716 | 44,286 | 41,109 | 40,304 | 39,175 |
Revenue Growth | 11.00% | 5.49% | 7.73% | 2.00% | 2.88% | 4.83% |
Gross Profit Gross Profit Growth | 37,565 | 33,793 | 31,091 | 28,490 | 28,435 | 26,924 |
Operating Income Operating Income Growth | 11,050 | 9,650 | 8,869 | 8,121 | 10,381 | 8,565 |
Net Income Net Income Growth | 4,178 | 7,813 | 5,560 | 5,400 | 8,371 | 6,223 |
Earnings Per Share EPS Growth | 3.46 | 6.37 | 4.44 | 4.31 | 6.67 | 4.95 |
EPS Growth | -53.23% | 43.55% | 2.94% | -35.31% | 34.73% | -49.28% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dupixent Dupixent Growth | 19,257 | 15,714 | 13,072 | 10,715 | 8,293 | 5,249 |
Pharma Pharma Growth | 40,186 | 35,690 | 32,783 | - | - | - |
Total Vaccine Total Vaccine Growth | 7,667 | 7,936 | 8,298 | 7,474 | 7,229 | 6,323 |
Revenue (Total) Revenue (Total) Growth | 50,982 | 46,716 | 44,286 | 41,618 | 40,561 | 39,175 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,966 | 7,674 | 7,556 | 8,822 | 12,882 | 10,109 |
Total Debt Total Debt Growth | 19,845 | 20,410 | 17,913 | 18,423 | 21,212 | 22,415 |
Net Cash (Debt) Net Cash Growth | -13,879 | -12,736 | -10,357 | -9,601 | -8,330 | -12,306 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11.48 | -10.39 | -8.25 | -7.64 | -6.63 | -9.78 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 11,959 | 10,750 | 9,081 | 10,258 | 10,526 | 10,522 |
Capital Expenditures CapEx Growth | -1,986 | -1,762 | -1,733 | -1,619 | -1,529 | -1,478 |
Free Cash Flow Free Cash Flow Growth | 9,973 | 8,988 | 7,348 | 8,639 | 8,997 | 9,044 |
Free Cash Flow Growth | 6.29% | 22.32% | -14.94% | -3.98% | -0.52% | 46.72% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.68% | 72.34% | 70.20% | 69.30% | 70.55% | 68.73% |
Operating Margin | 21.67% | 20.66% | 20.03% | 19.75% | 25.76% | 21.86% |
Pretax Margin | 11.59% | 12.89% | 15.26% | 14.88% | 24.79% | 20.01% |
Profit Margin | 8.20% | 16.72% | 12.55% | 13.14% | 20.77% | 15.88% |
FCF Margin | 19.56% | 19.24% | 16.59% | 21.02% | 22.32% | 23.09% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.120 | 4.120 | 3.920 | 3.760 | 3.560 | 3.330 |
Dividend Per Share Growth | 5.10% | 5.10% | 4.25% | 5.62% | 6.91% | 4.06% |
Dividend Yield | 5.09% | 4.94% | 4.20% | 4.18% | 3.96% | 3.75% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.42 | 12.88 | 21.04 | 20.84 | 13.46 | 17.87 |
Forward PE | 8.81 | 10.03 | 11.50 | 11.13 | 10.60 | 12.54 |
P/FCF Ratio | 9.73 | 11.20 | 15.92 | 13.03 | 12.52 | 12.30 |
PS Ratio | 1.90 | 2.15 | 2.64 | 2.74 | 2.80 | 2.84 |